EUVIMEDEUVIMED entdecken
Open Access

Genome Sequencing of Undiagnosed European Patients Suspected of Hereditary Cancer: Diagnostic Yield and Identification of Candidate Causative Variants

Nelson Martins iD, Mariona Terradas iD, José Garcia-Pelaez iD, Anna K Sommer iD, German Demidov iD, Leslie Matalonga iD, Mireia Ramos-Muntada iD, Iris B A W Te Paske, Isabel Spier, Arjen Mensenkamp iD, Janneke Schuurs-Hoeijmakers, Irene Gullo iD und 23 weitere

JCO Precision Oncology · 2026

DOI: 10.1200/po-25-00354 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCO Precision Oncology, 2026. Verfasst von Nelson Martins und 34 weiteren Autor:innen. Beteiligte Einrichtung: i3S - Instituto de Investigação e Inovação em Saúde da Universidade do Porto, Porto, Portugal. Hauptthemen laut MEDLINE: Neoplastic Syndromes, Hereditary, Whole Genome Sequencing. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE Hereditary cancers represent 5%-10% of all cancers, typically characterized by familial aggregation, early onset, and/or multiple primary tumors. Isolated cases with extreme early-onset or multiple unrelated cancers are rare and frequently underdiagnosed. This study aimed to improve genetic diagnostic yield in unresolved patients with strong clinical suspicion of hereditary cancer. Inclusion criteria were (1) ≥4 primary tumors in different organs (or ≥3 if two are rare), (2) adult-type cancers at ≤25 years, or (3) profuse gastrointestinal adenomatous polyposis before age 50 years or profuse polyposis of unknown type before age 30 years. METHODS Germline DNA from 98 patients selected through ERN-GENTURIS underwent short-read whole-genome sequencing (WGS). Ninety had received negative results from standard genetic testing, whereas eight had not been tested. Variant analysis was performed using the RD-Connect GPAP and Solve-RD frameworks. RESULTS Pathogenic or likely pathogenic variants in phenotype-related high-penetrance genes were found in 6% of patients, including APC and TP53 mosaicisms and germline variants in TP53 , BAP1 , BARD1 , and MBD4 (homozygous). Three patients carried pathogenic variants in hereditary cancer genes unrelated to their phenotype, and a heterozygous ERCC3 pathogenic variant was detected in a young patient with breast cancer. Suggestive variants of uncertain significance were identified, including a chromosome 3 inversion affecting VHL and MLH1 in a patient with renal and gastric cancers. Potentially regulatory noncoding variants in phenotype-associated genes were observed in 15% of patients (22 variants). CONCLUSION Comprehensive resequencing of patients suspected of hereditary cancer increased the diagnostic yield by 6%. Detected pathogenic variants involved phenotype-related genes not previously analyzed or missed because of mosaicism. WGS further enables identification of novel gene associations and structural, deep intronic, or regulatory variants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplastic Syndromes, HereditaryWhole Genome SequencingAdolescentAdultFemaleHumansMaleMiddle AgedYoung AdultEuropean PeopleGenetic Predisposition to DiseaseGenetic Testing

Autor:innen und Institutionen

  • i3S - Instituto de Investigação e Inovação em Saúde da Universidade do Porto, Porto, Portugal.
  • Ipatimup, Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal.
  • Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.
  • Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.
  • Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
  • Cell Biology, Physiology and Immunology Department, Faculty of Medicine, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Spain.

ORCID-Profile: Nelson Martins, Mariona Terradas, José Garcia-Pelaez, Anna K Sommer, German Demidov, Leslie Matalonga, Mireia Ramos-Muntada, Arjen Mensenkamp, Irene Gullo, Celina São José, Raquel Gouveia Silva, Ana Berta Sousa, Susana Fernandes, Luzia Garrido, Sofia Maia, Gabriela Sousa, Arvids Irmejs, Valeria Barili, Ana Blatnik, Paula Rofes, Joan Brunet, Gabriel Capellá, Steven Laurie, Conxi Lázaro, Nicoline Hoogerbrugge, Richarda M de Voer, Stefan Aretz, Carla Oliveira, Laura Valle

Zitieren

APA

Martins, N., Terradas, M., Garcia-Pelaez, J., Sommer, A. K., Demidov, G., Matalonga, L., Ramos-Muntada, M., Te Paske, I. B. A. W., Spier, I., Mensenkamp, A., Schuurs-Hoeijmakers, J., Gullo, I., São José, C., Pedro, A. M., Gouveia Silva, R., Sousa, A. B., Amoroso Canão, P., Fernandes, S., Garrido, L., …, & Valle, L. (2026). Genome Sequencing of Undiagnosed European Patients Suspected of Hereditary Cancer: Diagnostic Yield and Identification of Candidate Causative Variants. JCO Precision Oncology. https://doi.org/10.1200/po-25-00354

Vancouver

Martins N, Terradas M, Garcia-Pelaez J, Sommer AK, Demidov G, Matalonga L, et al. Genome Sequencing of Undiagnosed European Patients Suspected of Hereditary Cancer: Diagnostic Yield and Identification of Candidate Causative Variants. JCO Precision Oncology. 2026. doi:10.1200/po-25-00354

BibTeX
@article{Martins2026,
  author = {Martins, Nelson and Terradas, Mariona and Garcia-Pelaez, José and Sommer, Anna K and Demidov, German and Matalonga, Leslie and Ramos-Muntada, Mireia and Te Paske, Iris B A W and Spier, Isabel and Mensenkamp, Arjen and Schuurs-Hoeijmakers, Janneke and Gullo, Irene and São José, Celina and Pedro, Ana Maria and Gouveia Silva, Raquel and Sousa, Ana Berta and Amoroso Canão, Pedro and Fernandes, Susana and Garrido, Luzia and Dupont, Juliette and Maia, Sofia and Sousa, Gabriela and Irmejs, Arvids and Barili, Valeria and Blatnik, Ana and Rofes, Paula and Brunet, Joan and Capellá, Gabriel and Laurie, Steven and Lázaro, Conxi and Hoogerbrugge, Nicoline and de Voer, Richarda M and Aretz, Stefan and Oliveira, Carla and Valle, Laura},
  title = {Genome Sequencing of Undiagnosed European Patients Suspected of Hereditary Cancer: Diagnostic Yield and Identification of Candidate Causative Variants},
  journal = {JCO Precision Oncology},
  year = {2026},
  doi = {10.1200/po-25-00354}
}
Kostenlos starten →